secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bolt Biotherapeutics, Inc. (BOLT)
CIK:        0001641281
Form:       8-K
Filed at:   2024-07-03T23:59:59+00:00
Accession:  0001193125-24-175113
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Bolt Biotherapeutics receives Nasdaq bid price deficiency notice; 180 days to comply
--------------------------------------------------------------------------------

- Avg closing price of common stock fell below $1.00 over prior 30 trading days as of July 1, 2024.
- 180-day grace period until Dec 30, 2024 to regain compliance by closing at $1.00+ for 10 consecutive business days.
- If not compliant, may qualify for an additional 180-day extension if other listing standards met.
- Company intends to monitor bid price and evaluate options including potential reverse stock split.
- Notice has no immediate effect on listing; stock continues trading on Nasdaq Global Select Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641281/000119312524175113/0001193125-24-175113-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641281/000119312524175113/d796654d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-175113

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer